Smrithi S. Menon
Fred Hutchinson Cancer Center, St. Jude Children's Research Hospital, University of Toledo, Georgetown University, Amrita Vishwa Vidyapeetham - Kochi Campus
About
I am a postdoctoral research fellow in the Thomas Laboratory, where I began my training at St. Jude Children's Research Hospital and continue my work following the laboratory's transition to Fred Hutch Cancer Center in November 2025. My research focuses on immune dysfunction in pediatric cancer survivors and the immune determinants of infectious disease outcomes in children. Using a translational immunology approach, I leverage well-characterized human cohorts, high-dimensional immune profiling, and clinical data to investigate how cancer therapy and other immune perturbations shape long-term immune health.
My current research integrates high-dimensional spectral flow cytometry, single-cell transcriptomics (10x Genomics), and T cell receptor (TCR) repertoire sequencing to define immune phenotypes and clonal dynamics associated with chronic health burden and infection susceptibility. These multimodal platforms enable deep profiling of immune cell heterogeneity and adaptive immune remodeling, with the ultimate goal of informing precision survivorship care.
I completed my PhD in Biomedical Sciences at the University of Toledo, where I investigated the role of the complement system in host–pathogen interactions, sparking a broader interest in immune regulation and innate–adaptive crosstalk. During this time, I developed strong molecular and cellular biology skills, including complement assays, specialized ELISA's, flow cytometry, and protozoan parasite handling, specifically Trypanosoma cruzi, the causative agent of Chagas disease.
Prior to this, I earned an MS in Tumor Biology from Georgetown University, where I trained in cancer biology and metabolomics. I gained hands-on experience in mass spectrometry-based targeted metabolic profiling. Earlier in my career, following my undergraduate training, I worked in a clinical radiotherapy setting in India, where I gained experience with handling linear accelerators, cobalt-60 machines, and diagnostic imaging modalities (CT, MRI).
My long-term research interests lie at the intersection of immunology, cancer biology, and infectious disease. I am particularly motivated to understand how cancer therapies reprogram the immune system and how these alterations influence future immune resilience, chronic inflammation, and risk for infection or other late effects. By integrating cutting-edge single-cell tools with human cohort-based research, I aim to identify biomarkers and mechanisms that can guide risk stratification and therapeutic interventions for pediatric cancer survivors.
Employment
-
Fred Hutchinson Cancer Center Post doctoral Research fellow2025 - Present
-
St. Jude Children's Research Hospital Post-doctoral Research Fellow2023 - 2025
-
Georgetown University Research Assistant2015 - 2017
-
Narayana Health Radiotherapy Technologist2012 - 2014
Education
-
University of Toledo PhD in Medical Microbiology and Immunology2017 - 2023
-
Georgetown University MS in Tumor Biology2014 - 2015
-
Amrita Vishwa Vidyapeetham - Kochi Campus BSc in Medical Radiologic Technology2008 - 2012
Projects & Funding
Projects & funding information is unavailable.
Publications (12)
- Mechanisms by which Factor H protects Trypanosoma cruzi from the alternative pathway of complement. Save
- Baseline innate and T cell populations are correlates of protection against symptomatic influenza virus infection independent of serology. Save
- A novel assay that characterizes properdin function shows neutrophil-derived properdin has a distinct oligomeric distribution. Save
- Is It Possible to Intervene in the Capacity of Trypanosoma cruzi to Elicit and Evade the Complement System? Save
- Hijacking Factor H for Complement Immune Evasion. Save
- Properdin Is a Key Player in Lysis of Red Blood Cells and Complement Activation on Endothelial Cells in Hemolytic Anemias Caused by Complement Dysregulation. Save
- Discovery of Metabolic Biomarkers Predicting Radiation Therapy Late Effects in Prostate Cancer Patients. Save
- Metabolomics based predictive classifier for early detection of pancreatic ductal adenocarcinoma. Save
- Metabolomic and Lipidomic Profiling Identifies The Role of the RNA Editing Pathway in Endometrial Carcinogenesis. Save
- Metabolomic biomarkers of pancreatic cancer: a meta-analysis study. Save